Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC Trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, ss.103564, 2026 (SCI-Expanded, Scopus)